https://www.admarebio.com/en/ 2024-12-13T14:24:42+00:00 1.00 https://www.admarebio.com/en/board-of-directors 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/management 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/who-we-are 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/overview-companies 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/internal-portfolio 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/companies-weve-helped-build 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/accelerator 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/overview-ecosystems 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/innovation-centres 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/admare-community 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/overview-talent 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/executive-institute 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/bis-program 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/experiential-learning 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/admare-institute 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/news 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/events 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/culture 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/press-room 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/contact-us 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/newsletter 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/terms-and-conditions 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/fr/accueil 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/news-details/admare-welcomes-cohort-vii-of-the-executive-institute 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/news-details/kisoji-biotechnology-raises-41-million-advance-lead-program 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/en/news-details/admare-spins-out-analytical-services-to-paraza 2024-12-13T14:24:42+00:00 0.80 https://www.admarebio.com/fr/conseil-d-administration 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/equipe-de-direction 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/qui-nous-sommes 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/apercu-compagnies 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/portfolio-interne 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/accelerator-companies 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/26-therapeutics 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/abdera-therapeutics-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/arna-therapeutics-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/artelo-biosciences 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/bellus-health-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/bright-angel-therapeutics-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/domain-therapeutics-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/encycle-therapeutics-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/epigene-therapeutics-inc 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/epitopea 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/eupraxia-pharmaceuticals-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/evolved-therapeutics 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/find-therapeutics-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/flosonics-medical-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/forus-therapeutics-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/immugenia-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/inversago-pharma-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/jenthera-therapeutics-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/kairos-therapeutics-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/kalgene-phamaceuticals-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/kisoji-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/mesentech-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/neurasic-therapeutics-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/nexelis-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/nimium-therapeutics-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/ob-pharmaceuticals 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/overture-therapeutics 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/precision-nanosystems-inc-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/sepset-biosciences-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/sitka-biopharma-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/soundbite-medical-solutions-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/specific-biologics-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/specificit-pharma 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/thryv-therapeutics-inc-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/vida-therapeutics-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/zucara-therapeutics-inc-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/companies-weve-helped-build/zymeworks-inc-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/accelerateur 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/accelerator-application-v2 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/accelerator/9bio-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/accelerator/northmirs-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/accelerator/qthero-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/accelerator/rejuvenrx-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/accelerator/seragene-therapeutics-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/accelerator/tatum-bioscience-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/accelerator/telescope-therapeutics 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/pilot-accelerator 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/news-details/admare-accerelator-companies-mars 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/news-details/admare-academy-opens-applications-for-cohort-vii-of-its-executive-institute 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/news/ 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/apercu-ecosystemes 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/centres-d-innovation 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/aptochem 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/bioauxilium 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/cerasp 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/congruence-therapeutics 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/cura-therapeutics 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/cxc 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/cyclenium-pharma 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/copy---domain-therapeutics 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/domain-therapeutics 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/engene 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/evolved-therapeutics 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/find-therapeutics 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/jenthera 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/kdm 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/nanovation-therapeutics 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/nuchem-sciences 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/paraza 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/phebra-canada-inc 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/repare-therapeutics 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/resilience-biosciences 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/reverb-therapeutics 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/seragene-therapeutics 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/targa-biomedical 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/telescope-therapeutics 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/ucm-technologies 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/ecosystems-details/ventus 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/communaute-admare 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/apercu-talent 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/institut-pour-cadres-superieurs 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/programme-bis 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/apprentissage-experientiel 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/institut-admare 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/actualites 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/news?keywords[]=7255 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/news?keywords[]=7256 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/news?keywords[]=7258 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/news?keywords[]=7257 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/news?keywords[]=7259 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/news-details/zymeworks-receives-fda-grants-approval-ziihera 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/news-details/thryv-announces-completion-phase-1 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/news-details/zucara-announce-serie-b-financing 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/news-details/zymeworks-announces-first-patient-dosed-in-phase-1-clinical-trial-evaluating-zw171 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/news-details/cancer-research-uk-and-kisoji-biotechnology-collaborate 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/news-details/epitopea-closes-usd-31-million-pre-series-a-financing 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/news-details/find-therapeutics-announces-first-subject-dosed-in-phase-1-clinical-study-of-ftx-101 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/news-details/thryv-therapeutics-receives-positive-top-line-results-from-wave-i-part-2-clinical-study 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/evenements 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/culture 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/salle-de-presse 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/press-release-details/admare-spins-out-analytical-services-to-paraza 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/press-release-details/epitopea-closes-usd-31-million-pre-series-a-financing 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/press-release-details/thryv-therapeutics-granted-fda-orphan-drug-designation 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/press-release-details/admare-appoints-marc-riviere 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/press-release-details/nanovation-therapeutics-announces-multi-target-partnership-with-novo-nordisk 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/press-release-details/find-therapeutics-announces-the-closing-of-a-convertible-note-financing-with-investissement-quebec 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/contactez-nous 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/bulletin 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/termes-et-conditions 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/ 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/en/home 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/actualites-details/admare-accueille-cohorte-vii-institut-cadres-superieur 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/actualites-details/kisoji-biotechnology-41-millions-avancer-programme-principal 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/actualites-details/admare-transfere-services-analytiques-paraza 2024-12-13T14:24:42+00:00 0.64 https://www.admarebio.com/fr/accelerateur-compagnies 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/26-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/abdera-therapeutics-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/arna-therapeutics-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/artelo-biosciences 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/bellus-health-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/bright-angel-therapeutics-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/domain-therapeutics-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/encycle-therapeutics-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/epigene-therapeutics-inc 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/epitopea 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/eupraxia-pharmaceuticals-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/evolved-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/find-therapeutics-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/flosonics-medical-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/forus-therapeutics-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/immugenia-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/inversago-pharma 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/jenthera-therapeutics-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/kairos-therapeutics-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/kalgene-phamaceuticals 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/kisoji 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/mesentech-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/neurasic-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/nexelis-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/nimium-therapeutics-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/ob-pharmaceuticals 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/overture-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/precision-nanosystems-inc-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/sepset-biosciences-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/sitka-biopharma-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/soundbite-medical-solutions 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/specific-biologics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/specificit-pharma 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/thryv-therapeutics-inc 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/vida-therapeutics-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/zucara-therapeutics-inc 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/zymeworks-inc 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/accelerator-companies/9bio 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/accelerator-companies/cura-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/accelerator-companies/modelis 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/accelerator-companies/molecular-forecaster 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/accelerator-companies/northmirs 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/accelerator-companies/qthero 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/accelerator-companies/rejuvenrx 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/accelerator-companies/seragene-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/accelerator-companies/targa-biomedical 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/accelerator-companies/tatum-bioscience 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/accelerator-companies/telescope-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/accelerator-companies/trepso-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/accelerator-companies/valence-discovery 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/admare-launches-abdera-with-abcellera-as-a-founding-partner 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/accelerateur-application-v2 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/accelerateur/9bio-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/accelerateur/northmirs-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/accelerateur/qthero-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/accelerateur/rejuvenrx-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/accelerateur/seragene-therapeutics-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/accelerateur/tatum-bioscience-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/accelerateur/telescope-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/projet-pilote-accelerateur 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/actualites-details/admare-national-accelerator-mars 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/actualites-details/lacademie-admare-ouvre-les-candidatures-pour-la-cohorte-vii-de-son-institut-pour-cadres-superieurs 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/accelerator/www.linkedin.com/company/northmirs 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/pilot-accelerator/cura-therapeutics-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/pilot-accelerator/modelis-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/pilot-accelerator/molecular-forecaster-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/pilot-accelerator/targa-biomedical-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/pilot-accelerator/trepso-therapeutics-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/pilot-accelerator/valence-discovery-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news/?keywords[]=7257 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news/?keywords[]=7258 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news/?keywords[]=7255 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news/?keywords[]=7259 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/aptochem 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/bioauxilium 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/cerasp 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/congruence-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/cura-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/cxc 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/cyclenium-pharma 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/copie---domain-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/domain-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/engene 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/copie---engene 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/find-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/jenthera 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/kdm 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/nanovation-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/nuchem-sciences 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/paraza 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/phebra-canada-inc 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/repare-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/resilience-biosciences 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/reverb-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/seragene-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/targa-biomedical 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/telescope-therapeutics 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/ucm-technologies 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/des-ecosystemes-details/ventus 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/actualites?keywords[]=7255 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/actualites?keywords[]=7256 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/actualites?keywords[]=7258 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/actualites?keywords[]=7257 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/actualites?keywords[]=7259 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/actualites-details/zymerworks-obtains-fda-grants-approval-ziihera 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/actualites-details/thryv-annonce-dosage-phase-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/actualites-details/zucara-financement-serie-b-sanofi 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/actualites-details/zymeworks-announces-first-patient-dosed-in-phase-1-clinical-trial-evaluating-zw171 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/actualites-details/cancer-research-uk-et-kisoji-biotechnology-collaborent 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/actualites-details/epitopea-conclut-des-ententes-de-financement-prealable-a-la-serie-a 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/actualites-details/find-therapeutics-announces-first-subject-dosed-in-phase-1-clinical-study-of-ftx-101 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/actualites-details/thryv-therapeutics-receives-positive-top-line-results-from-wave-i-part-2-clinical-study 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/thryv-therapeutics-granted-fda-orphan-drug-designation 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/admare-appoints-marc-riviere 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/nanovation-therapeutics-announces-multi-target-partnership-with-novo-nordisk 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news?keywords[]=7280 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/find-therapeutics-announces-the-closing-of-a-convertible-note-financing-with-investissement-quebec 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/abdera-therapeutics-announces-fda-orphan-drug-designation-for-abd-147 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/pharmaessentia-announces-licensing-agreement-with-forus-therapeutics-3 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/sofiac-admare-announce-investment 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/admare-bioinnovations-opens-applications-for-the-fall-cohorts-of-the-bioinnovation-scientist-programs 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/admare-bioinnovations-expands-with-new-wet-laboratory-space-in-vancouver 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/landmark-report-published-on-the-status-of-inclusion-diversity-equity-and-accessibility-idea-in-canada-s-life-sciences-sector 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/abdera-s-success-admare-model-of-company-creation 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/admare-s-company-co-creation-model---a-pioneering-approach-in-canadian-life-sciences-industry 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/how-canada-can-prevent-a-future-moderna-from-slipping-away 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/highlights-of-the-global-leaders-series-with-dr-james-sabry 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/fda-clears-finds-ind-for-phase-1-study-of-ftx-101 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/sutter-health-deploys-worlds-first-wearable-doppler-ultrasound-patch-to-enhance-safety-of-icu-patients 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/copy---castl-partners-with-moderna-canada-to-ready-workforce-at-laval-manufacturing-site 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/biotalent-canada-and-castl-partner-to-support-talent-development-in-canadas-biomanufacturing-sector 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/admare-bioinnovations-opens-applications-for-cohort-iii-of-the-bioinnovation-scientist-program-foundations-and-launches-new 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/castl-partners-with-moderna-canada-to-ready-workforce-at-laval-manufacturing-site 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/admare-bioinnovations-welcomes-22-influential-life-sciences-leaders-to-cohort-vi-of-the-admare-academy-executive-institute 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/castl-opens-biomanufacturing-training-facility-in-quebec 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/admare-bioinnovations-invites-early-career-science-professionals-to-apply-to-the-bioinnovation-scientist-bis-program-foundations-cohort-ii 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/applications-now-open-for-the-admare-executive-institute-cohort-vi-program 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/admare-bioinnovations-launches-bis-program-foundations 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/castl-partners-with-british-columbia-institute-of-technology-on-new-biomanufacturing-training-facility 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/admare-bioinnovations-welcomes-five-new-start-ups-in-the-national-tx-accelerator 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/admare-bioinnovations-and-mars-discovery-district-welcome-inaugural-ontario-start-ups-to-therapeutics-accelerator-program 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/recursion-enters-into-agreements-to-acquire-cyclica-and-valence-to-bolster-chemistry-and-generative-ai-capabilities 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/mars-partners-with-admare-bioinnovations-to-develop-therapeutics-accelerator 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/admare-bioinnovations-launches-the-admare-tx-accelerator-to-support-growth-of-promising-early-stage-therapeutics-ventures-across-canada 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/admare-bioinnovations-collaborates-with-accelerator-company-molecular-forecaster-inc-on-computational-approaches-to-drug-discovery 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/admare-s-accelerate-quebec-company-molecular-forecaster-continues-quest-to-fast-track-drug-discovery-with-two-new-public-private-partnerships 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/admare-bioinnovations-welcomes-the-first-quebec-start-ups-in-its-accelerate-program 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/news-details/admare-bioinnovations-launches-a-new-acceleration-program-for-quebec-emerging-companies 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/communiques-de-presse-details/admare-transfere-services-analytiques-paraza 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/communiques-de-presse-details/epitopea-conclut-des-ententes-de-financement-prealable-a-la-serie-a 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/communiques-de-presse-details/thryv-therapeutics-granted-fda-orphan-drug-designation-for-lqt-1213-in-long-qt-syndrome-treatment 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/communiques-de-presse-details/admare-nomme-marc-riviere 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/communiques-de-presse-details/nanovation-therapeutics-announces-multi-target-partnership-with-novo-nordisk 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/communiques-de-presse-details/find-therapeutiques-annonce-la-cloture-dun-financement-par-debentures-convertibles-avec-investissement-quebec 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/press-release-details/admare-welcomes-cohort-vii-of-the-executive-institute 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/press-release-details/kisoji-biotechnology-raises-41-million-advance-lead-program 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/press-release-details/zymeworks-receives-fda-grants-approval-ziihera 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/press-release-details/thryv-announces-completion-phase-1 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/en/press-releases 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/communiques-de-presse-details/125667 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/communiques-de-presse-details/124901 2024-12-13T14:24:42+00:00 0.51 https://www.admarebio.com/fr/accelerateur-compagnies/9bio 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/accelerateur-compagnies/cura-therapeutics 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/accelerateur-compagnies/modelis 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/accelerateur-compagnies/molecular-forecaster 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/accelerateur-compagnies/northmirs 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/accelerateur-compagnies/qthero 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/accelerateur-compagnies/rejuvenrx 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/accelerateur-compagnies/seragene-therapeutics 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/accelerateur-compagnies/targa-biomedical 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/accelerateur-compagnies/tatum-bioscience 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/accelerateur-compagnies/telescope-therapeutics 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/accelerateur-compagnies/trepso-therapeutics 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/accelerateur-compagnies/valence-discovery 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/les-entreprises-que-nous-avons-aide-a-developper/ 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/accelerator-companies/www.linkedin.com/company/northmirs 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/admare-lance-abdera-avec-abcellera-en-tant-que-partenaire-fondateur 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/accelerateur/www.linkedin.com/company/northmirs 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/projet-pilote-accelerateur/cura-therapeutics-1 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/projet-pilote-accelerateur/modelis-1 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/projet-pilote-accelerateur/molecular-forecaster-1 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/projet-pilote-accelerateur/targa-biomedical-1 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/projet-pilote-accelerateur/trepso-therapeutics-1 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/projet-pilote-accelerateur/valence-discovery-1 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/pilot-accelerator/ 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/news/?keywords[]=7280 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/thryv-therapeutics-granted-fda-orphan-drug-designation-for-lqt-1213-in-long-qt-syndrome-treatment 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/admare-nomme-marc-riviere 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/nanovation-therapeutics-announces-multi-target-partnership-with-novo-nordisk 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/find-therapeutiques-annonce-la-cloture-dun-financement-par-debentures-convertibles-avec-investissement-quebec 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/abdera-therapeutics-announces-fda-orphan-drug-designation 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/pharmaessentia-announces-licensing-agreement-with-forus-therapeutics 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/sofiac-canada-investissement-admare 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/admare-bioinnovations-ouvre-les-candidatures-pour-les-cohortes-dautomne-des-programmes-scientifiques-en-bioinnovation 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/admare-bioinnovations-sagrandit-avec-un-nouvel-espace-de-laboratoires-a-vancouver 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/publication-d-un-rapport-de-reference-intitule-etat-de-l-inclusion-de-la-diversite-de-l-equite-et-de-l-accessibilite-idea 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/le-succes-dabdera-le-modele-admare-de-creation-dentreprise 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/le-modele-de-cocreation-d-entreprise-d-admare-une-approche-pionniere-dans-l-industrie-canadienne-des-sciences-de-la-vie 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/how-canada-can-prevent-a-future-moderna-from-slipping-away 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/faits-saillants-de-la-serie-des-chefs-de-file-mondiaux-avec-le-dr-james-sabry 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/find-therapeutiques-annonce-lautorisation-par-la-fda-dune-demande-dind-pour-une-etude-de-phase-1-du-ftx-101 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/sutter-health-deploys-worlds-first-wearable-doppler-ultrasound-patch-to-enhance-safety-of-icu-patients 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/castl-annonce-la-nomination-dun-gestionnaire-de-site-pour-son-centre-de-formation-en-biofabrication-en-colombie-britannique 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/biotalent-canada-et-castl-etablissent-un-partenariat-pour-soutenir-le-developpement-des-talents-dans-le-secteur-canadien-de-la-biofabrication 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/admare-bioinnovations-ouvre-les-candidatures-pour-la-cohorte-iii-du-programme-scientifique-en-bioinnovation-fondements-et-lance-un-nouveau-programme 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/castl-sassocie-a-moderna-canada-pour-preparer-la-main-doeuvre-au-site-de-fabrication-de-laval 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/admare-bioinnovations-accueille-22-dirigeants-influents-du-secteur-des-sciences-de-la-vie-au-sein-de-la-cohorte-vi 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/castl-ouvre-un-centre-de-formation-en-biofabrication-au-quebec 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/admare-bioinnovations-invite-les-scientifiques-en-debut-de-carriere-a-poser-leur-candidature-pour-faire-partie-de-la-cohorte-ii 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/les-candidatures-sont-ouvertes-pour-le-programme-de-la-cohorte-vi-de-l-institut-pour-cadres-superieurs-de-l-academie-admare 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/admare-bioinnovations-lance-programme-bis-fondements 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/alliance-canadienne-pour-la-formation-et-le-developpement-de-competences-en-sciences-de-la-vie-s-associe-a-l-institut-de-technologie-de-la-colombie-britannique-pour-la-construction-d-un-nouveau-centre-de-formation-en- 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/admare-bioinnovations-accueille-cinq-nouvelles-start-ups-au-sein-de-laccelerateur-tx-national 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/admare-bioinnovations-et-mars-discovery-district-accueillent-les-premieres-entreprises-ontariennes-en-phase-de-demarrage-au-sein-de-l-accelerateur-tx 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/recursion-enters-into-agreements-to-acquire-cyclica-and-valence-to-bolster-chemistry-and-generative-ai-capabilities 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/mars-partners-with-admare-bioinnovations-to-develop-therapeutics-accelerator 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/admare-bioinnovations-lance-l-accelerateur-tx-admare-afin-de-soutenir-la-croissance-d-entreprises-therapeutiques-prometteuses-en-phase-de-demarrage-au-canada 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/molecular-forecaster-une-entreprise-du-programme-d-acceleration-d-admare-poursuit-sa-quete-pour-accelerer-la-decouverte-de-medicaments-grace-a-deux-nouveaux-partenariats-public-prive 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/admare-bioinnovations-accueille-les-premieres-compagnies-dans-son-programme-d-acceleration 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/admare-bioinnovations-lance-un-nouveau-programme-d-acceleration-pour-les-entreprises-emergentes-au-quebec 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/125667 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/124901 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/124459 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/124457 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/news-details/copy---zone-study-to-assess-zt-01-s-ability-to-prevent-night-time-hypoglycemia-a-condition-for-which-there-are-currently-no-available-therapies 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/bis-foundations-spring-application-2024 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/bis-industry-essentials-spring-application-2024 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/bis-foundations-fall-application 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/82370 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/actualites-details/82346 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/?page_id=11779 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/communiques-de-presse-details/admare-accueille-cohorte-vii-institut-cadres-superieur 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/communiques-de-presse-details/kisoji-biotechnology-41-millions-avancer-programme-principal 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/communiques-de-presse-details/zymerworks-obtains-fda-grants-approval-ziihera 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/communiques-de-presse-details/thryv-annonce-dosage-phase-1 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/125929 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/125930 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/communiques-de-presse 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/abdera-therapeutics-announces-fda-orphan-drug-designation-for-abd-147-1 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/pharmaessentia-announces-licensing-agreement-with-forus-therapeutics-1 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/sofiac-admare-announce-investment 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-opens-applications-for-the-fall-cohorts-of-the-bioinnovation-scientist-programs 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-expands-with-new-wet-laboratory-space-in-vancouver 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-academy-opens-applications-for-cohort-vii-of-its-executive-institute 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-welcomes-five-new-start-ups-in-the-national-tx-accelerator 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-opens-applications-for-cohort-iii-of-the-bioinnovation-scientist-program-foundations-and-launches-new 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-institute-speaking-series 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/happy-holidays-from-the-admare-bioinnovations-team 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-welcomes-22-influential-life-sciences-leaders-to-cohort-vi-of-the-admare-academy-executive-institute 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-institute-role-anchor-companies 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-launches-the-refreshed-version-of-the-admare-community-with-new-engaging-features 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-and-mars-discovery-district-welcome-inaugural-ontario-start-ups-to-therapeutics-accelerator-program 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-appoints-john-delucchi-martin-leblanc-and-tim-van-biesen-to-the-board-of-directors 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-invites-early-career-science-professionals-to-apply-to-the-bioinnovation-scientist-bis-program-foundations-cohort-ii 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/landmark-report-published-on-the-status-of-inclusion-diversity-equity-and-accessibility-idea-in-canada-s-life-sciences-sector 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/cpdc-funds-research-at-simon-fraser-university-for-developing-an-lat1-targeting-pet-tracer-for-imaging-cancer 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/applications-now-open-for-the-admare-executive-institute-cohort-vi-program 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-launches-the-admare-institute 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-acheive-leed-certification 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/new-strategy-bc-hub-science 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-launches-bis-program-foundations 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/mars-partners-with-admare-bioinnovations-to-develop-therapeutics-accelerator 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-and-prime-next-generation-precision-medicine-collaborate-to-translate-academic-research-into-life-changing-therapeutics 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-launches-the-admare-tx-accelerator-to-support-growth-of-promising-early-stage-therapeutics-ventures-across-canada 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-appoints-travis-mccready-to-the-board-of-directors 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-and-medicine-by-design-partner-to-support-translation-priorities-in-the-toronto-life-sciences-ecosystem 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/immugenia-obtains-pre-seed-funding-from-admare-bioinnovations-acet-capital-and-sherbrooke-innopole-to-develop-a-cancer-treatment-which-would-prevent-relapses 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-announces-a-strong-cohort-for-its-academy-s-executive-institute-2022-2023-program 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/new-partnership-between-genome-canada-and-admare-bioinnovations-to-drive-commercialization-of-genomics-solutions-in-healthcare 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/canadian-biotech-industry-recognizes-top-performers 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-appoints-patricia-gauthier-to-the-board-of-directors 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/anie-perrault-joins-admare-as-vice-president-public-affairs-and-communications 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-appoints-dr-christine-allen-as-vice-president-ecosystem-development 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-joins-a-42m-series-a-financing-in-domain-therapeutics 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-collaborates-with-accelerator-company-molecular-forecaster-inc-on-computational-approaches-to-drug-discovery 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/government-of-canada-invests-92-million-in-admare-to-help-translate-health-research-into-innovative-new-therapies-in-canada 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-supports-ukraine-responds-to-ministers-champagne-and-duclos 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/specific-biologics-closes-seed-financing-with-industry-leaders-lumira-ventures-and-admare-bioinnovations 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-announces-successful-applicants-to-2021-2022-executive-institute 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-and-uottawa-work-together-to-translate-university-research-into-strong-new-canadian-life-science-companies 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-and-castl-partner-to-build-canada-s-biomanufacturing-talent 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-and-district-3-innovation-partner-to-provide-science-based-canadian-startups-more-cohesive-support-to-grow-into-industry-leaders 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-s-president-ceo-gordon-c-mccauley-is-appointed-to-biovectra-board-of-directors 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-and-aazeintx-inc-sign-global-exclusive-agreement 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-launches-canada-s-first-only-digital-life-sciences-community 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/new-canadian-pharmaceutical-company-brings-novel-cancer-therapies-to-market 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-launches-abdera-with-abcellera-as-a-founding-partner 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/join-us-in-the-50-30-challenge 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-welcomes-the-first-quebec-start-ups-in-its-accelerate-program 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/developing-canada-s-next-generation-of-commercial-life-scientists 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/didier-leconte-elected-chair-of-admare-board 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/unleashing-canada-s-radiopharmaceutical-excellence 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/global-pandemic-drives-unprecedented-need-to-grow-canada-s-life-science-leadership 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-is-pleased-to-increase-our-investment-in-inversago-pharma-alongside-leading-life-sciences-investors-and-be-a-part-of-building-this-exceptional-canadian-company-developing-innovative-therapies 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/cdl-health-and-admare-bioinnovations-partner-to-accelerate-the-commercialization-of-health-innovations 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-launches-a-new-acceleration-program-for-quebec-emerging-companies 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-strengthens-leadership-team 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/find-therapeutics-a-new-drug-development-company-dedicated-to-breakthrough-therapies-against-rare-diseases-launches-in-montreal 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/new-company-to-advance-research-into-made-in-canada-therapy-for-patients-with-chronic-pain 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-academy-executive-institute-developing-canada-s-life-sciences-leaders-in-a-covid-world-and-beyond 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/on-the-cutting-edge-of-the-fight-against-the-pandemic 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-and-bellus-health-close-transaction-for-intellectual-property-rights-to-p2x3-platform 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-accel-rx-unite-to-advance-the-canadian-life-sciences-sector 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-appoints-dr-mounia-azzi-as-vice-president-program-development-and-partnerships 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-academy-announces-new-executive-institute-cohort-to-drive-the-canadian-life-sciences-industry-forward 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/life-sciences-health-technology-innovation-hub-takes-shape-in-montreal 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/admare-bioinnovations-appoints-dr-youssef-bennani-as-venture-partner 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/cdrd-neomed-institute-join-forces-to-create-a-new-pan-canadian-enterprise-admare-bioinnovations 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/125667 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/en/press-release-details/124901 2024-12-13T14:24:42+00:00 0.41 https://www.admarebio.com/fr/accelerateur-compagnies/www.linkedin.com/company/northmirs 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/projet-pilote-accelerateur/ 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/en/news-details/125929 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/en/news-details/125930 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/en/news-details/125931 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/en/news-details/125932 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/actualites-details/copie---zone-study-to-assess-zt-01-s-ability-to-prevent-night-time-hypoglycemia-a-condition-for-which-there-are-currently-no-available-therapies 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/en/bis-foundations-spring-application-2024/ 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/bis-industry-essentials-spring-application-2024 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/bis-foundations-fall-application 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/en/news-details/82347 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/en/?page_id=10924&lang=fr 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/en/?lang=fr 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/en/?page_id=8603&lang=fr 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/en/news-details/125667 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/en/news-details/124901 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/en/news-details/124459 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/en/news-details/124457 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/bis-foundations-spring-application-2024 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/en/news-details/82370 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/en/news-details/82346 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/125929 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/125930 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/abdera-therapeutics-announces-fda-orphan-drug-designation 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/pharmaessentia-announces-licensing-agreement-with-forus-therapeutics 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/sofiac-canada-investissement-admare 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/admare-bioinnovations-ouvre-les-candidatures-pour-les-cohortes-dautomne-des-programmes-scientifiques-en-bioinnovation 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/admare-bioinnovations-sagrandit-avec-un-nouvel-espace-de-laboratoires-a-vancouver 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/lacademie-admare-ouvre-les-candidatures-pour-la-cohorte-vii-de-son-institut-pour-cadres-superieurs 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/admare-bioinnovations-accueille-cinq-nouvelles-start-ups-au-sein-de-laccelerateur-tx-national 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/admare-bioinnovations-ouvre-les-candidatures-pour-la-cohorte-iii-du-programme-scientifique-en-bioinnovation-fondements-et-lance-un-nouveau-programme 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/institut-admare-serie-evenement 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/lequipe-dadmare-bioinnovations-vous-souhaite-de-joyeuses-fetes-de-fin-dannee 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/admare-bioinnovations-accueille-22-dirigeants-influents-du-secteur-des-sciences-de-la-vie-au-sein-de-la-cohorte-vi 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/institut-admare-role-societes-dancrage 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/admare-bioinnovations-lance-la-nouvelle-version-de-la-communaute-admare-avec-de-nouvelles-fonctionnalites 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/admare-bioinnovations-et-mars-discovery-district-accueillent-les-premieres-entreprises-ontariennes-en-phase-de-demarrage-au-sein-de-l-accelerateur-tx 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/admare-bioinnovations-nomme-john-delucchi-martin-leblanc-et-tim-van-biesen-au-conseil-d-administration 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/admare-bioinnovations-invite-les-scientifiques-en-debut-de-carriere-a-poser-leur-candidature-pour-faire-partie-de-la-cohorte-ii 2024-12-13T14:24:42+00:00 0.33 https://www.admarebio.com/fr/communiques-de-presse-details/publication-d-un-rapport-de-reference-intitule-etat-de-l-inclusion-de-la-diversite-de-l-equite-et-de-l-accessibilite-idea 2024-12-13T14:24:42+00:00 0.33